(Q46008345)

18 December 2017

title

A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease. (English)

1 reference

18 December 2017

0 references

Patrizio Pasqualetti

1

1 reference

18 December 2017

Cristina Bonomini

2

1 reference

18 December 2017

Gloria Dal Forno

3

1 reference

18 December 2017

Luca Paulon

4

1 reference

18 December 2017

Elena Sinforiani

5

1 reference

18 December 2017

Camillo Marra

6

1 reference

18 December 2017

Orazio Zanetti

7

1 reference

18 December 2017

Paolo Maria Rossini

8

1 reference

18 December 2017

publication date

1 April 2009

1 reference

18 December 2017

Aging Clinical and Experimental Research

published in

1 reference

18 December 2017

volume

21

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

102-110

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1007/bf03325217

exact match

0 references

cites work

Inflammation and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Polymorphisms in inflammatory genes and the risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Alzheimer's disease: a study of epidemiological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Rheumatoid arthritis and senile dementia of the Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Anti-inflammatory drugs and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

A case-control study of Alzheimer's disease in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

A case-control study of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Medical history and the risk of Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Rheumatoid arthritis and susceptibility to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

A case-control study of Alzheimer's disease in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Nonsteroidal antiinflammatory drug use in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Alzheimer's disease and rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Nonsteroidal anti-inflammatory drugs in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Risk of Alzheimer's disease and duration of NSAID use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Anti-inflammatory drugs protect against Alzheimer disease at low doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Nonsteroidal antiinflammatory drug use and cognitive function in the elderly: inconclusive results from a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Nonsteroidal anti-inflammatory drug use and Alzheimer's disease: a case-control study in Rochester, Minnesota, 1980 through 1984.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Clinical trial of indomethacin in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Long-term efficacy and safety of celecoxib in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Arthritis medicines and cardiovascular events--"house of coxibs".

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Development and validation of a geriatric depression screening scale: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Progress in Development of the Index of ADL

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

A new clinical scale for the staging of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Application of a multidimensional caregiver burden inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease?: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

NSAIDs and incident Alzheimer’s disease. the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03325217

21 January 2018

Identifiers

DOI

10.1007/BF03325217

1 reference

18 December 2017

1 reference

18 December 2017